Respiratory disease and respiratory physiology: Putting lung function into perspective interstitial lung disease

Respirology

Volumn 19, Issue 7, 2014, Pages 952-959

  Berend, Norbert ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Gas transfer; Idiopathic pulmonary fibrosis; Lung volume; Non specific interstitial pneumonia; Restrictive lung disease

Indexed keywords

TRANSFER FACTOR;

BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; EMPHYSEMA; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG VOLUME; PRESSURE VOLUME CURVE; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; COMPLICATION; LUNG DISEASES, INTERSTITIAL; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PULMONARY EMPHYSEMA;

HUMANS; LUNG DISEASES, INTERSTITIAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS;

EID: 84908657412     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12348     Document Type: Review

References (63)

1. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013;188:733-48.
2. Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, Travis WD, McCoy JP Jr, May RM, Wu HP, Nguyen DM et al. Early interstitial lung disease in familial pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007;176:698-705.
3. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1997;155:242-8.
4. Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61:980-5.
5. Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial pneumonia: histologic correlation with highresolution CT. Radiology 1992;182:337-42.
6. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722.
7. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-52.
8. Kurashima K, Takayanagi N, Tsuchiya N, Kanauchi T, Ueda M, Hoshi T, Miyahara Y, Sugita Y. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 2010;15:843-8.
9. Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suarez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009;136:10-15.
10. Cottin V, Nunes H, Brillet P-Y, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier J-F, the Groupe d'Etude et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005;26:586-93.
11. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G et al. I. P. F. Study Group. The clinical course of patients with idiopathic pulmonary fibrosis. Ann. Intern. Med.. 2005;142:963-7.
12. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007;176:636-43.
13. Kim EY, Lee KS, Chung MP, Kwon OJ, Kim TS, Hwang JH. Nonspecific interstitial pneumonia with fibrosis: serial highresolution CT findings with functional correlation. AJR Am. J. Roentgenol. 1999;173:949-53.
14. Akira M, Inoue Y, Arai T, Okuma T, Kawata Y. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011;66:61-5.
15. Ujita M, Renzoni EA, Veeraraghavan S, Wells AU, Hansell DM. Organizing pneumonia: perilobular pattern at thin-section CT. Radiology 2004;232:757-61.
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten C P M, Gustafsson P, Hankinson J et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005;26:948-68.
17. Portnoy J, Veraldi KL, Schwarz MI, Cool CD, Curran-Everett D, Cherniack RM, King TE Jr, Brown KK. Respiratory bronchiolitisinterstitial lung disease: long-term outcome. Chest 2007;131:664-71.
18. Figueira de Mello GC, Ribeiro Carvalho CR, Adib Kairalla R, Nascimento Saldiva PH, Fernezlian S, Ferraz Silva LF, Dolhnikoff M, Mauad T. Small airway remodeling in idiopathic interstitial pneumonias: a pathological study. Respiration 2010;79:322-32.
19. Gibson GJ, Pride NB. Lung distensibility. The static pressurevolume curve of the lungs and its use in clinical assessment. Br. J. Dis. Chest 1976;70:143-84.
20. Colebatch HJ, Greaves IA, Ng CK. Exponential analysis of elastic recoil and aging in healthy males and females. J. Appl. Physiol. 1979;47:683-91.
21. Sansores RH, Ramirez-Venegas A, Perez-Padilla R, Montano M, Ramos C, Becerril C, Gaxiola M, Pare P, Selman M. Correlation between pulmonary fibrosis and the lung pressure-volume curve. Lung 1996;174:315-23.
22. Verbeken EK, Cauberghs M, Lauweryns JM, Van deWoestijne KP. Structure and function in fibrosing alveolitis. J. Appl. Physiol. 1994;76:731-42.
23. Berend N, Feldsien D, Cederbaums D, Cherniack RM. Structurefunction correlation of early stages of lung injury induced by intratracheal bleomycin in the rabbit. Am. Rev. Respir. Dis. 1985;132:582-9.
24. Thompson MJ, Colebatch HJ. Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume. Thorax 1989;44:725-31.
25. Horiuchi T, Ikegami M, Cherniack RM, Mason RJ. Increased surface tension of the lung and surfactant in bleomycin-induced pulmonary fibrosis in rats. Am. J. Respir. Crit. Care Med. 1996;154:1002-5.
26. Bachofen H, Scherrer M. Lung tissue resistance in diffuse interstitial pulmonary fibrosis. J. Clin. Invest. 1967;46:133-40.
27. Nava S, Rubini F. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax 1999;54:390-5.
28. Gibson GJ. Lung volumes and elasticity. Clin. Chest Med. 2001;22:623-35.
29. Fulmer JD, Roberts WC, von Gal ER, Crystal RG. Morphologicphysiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J. Clin. Invest. 1979;63:665-76.
30. Chinet T, Jaubert F, Dusser D, Danel C, Chretien J, Huchon GJ. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 1990;45:675-8.
31. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am. Rev. Respir. Dis. 1981;124:1-8.
32. Guenard H, Varene N, Vaida P. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. Respir. Physiol. 1987;70:113-20.
33. Van der Lee I, Zanen P, Grutters JC, Snijder RJ, van den Bosch JM. Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest 2006;129:378-83.
34. Borland C. A place for TL, NO with TL, CO? Eur. Respir. J. 2008;31:918-19.
35. Peelen L, Wells AU, Prijs M, Blumenthal JP, van Steenwijk RP, Jonkers RE, Peek N, Bresser P. Fibrotic idiopathic interstitial pneumonias: mortality is linked to a decline in gas transfer. Respirology 2010;15:1233-43.
36. Jayamanne DS, Epstein H, Goldring RM. The influence of lung volume on expiratory flow rates in diffuse interstitial lung disease. Am. J. Med. Sci. 1978;275:329-36.
37. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 2001;164:1171-81.
38. Van Noord JA, Clement J, Cauberghs M, Mertens I, Van De Woestijne KP, Demedts M. Total respiratory resistance and reactance in patients with diffuse interstitial lung disease. Eur. Respir. J. 1989;2:846-52.
39. Mori K, Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Hozumi H, Suda T et al. Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema. Respir. Physiol. Neurobiol. 2013;185:235-40.
40. Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1991;144:504-6.
41. Lundblad LK, Thompson-Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, Bates JH. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005;171:1363-70.
42. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir. Med. 1990;84:365-9.
43. Burdon JG, Killian KJ, Jones NL. Pattern of breathing during exercise in patients with interstitial lung disease. Thorax 1983;38:778-84.
44. Javaheri S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax 1992;47:93-7.
45. Marciniuk DD, Sridhar G, Clemens RE, Zintel TA, Gallagher CG. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease. J Appl Physiol 1994;77:963-73.
46. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996;109:1566-76.
47. Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1991;143:219-25.
48. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Arizono S. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005;127:33.
49. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2005;171:1150-7.
50. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir. Med. 2009;103:117-23.
51. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP 3rd et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003;168:1084-90.
52. Swigris JJ, Swick J, Wamboldt FS, Sprunger D, du Bois R, Fischer A, Cosgrove GP, Frankel SK, Fernandez-Perez ER, Kervitsky D et al. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009;136:841-8.
53. Nathan SD, Shlobin OA, Barnett SD, Saggar R, Belperio JA, Ross DJ, Ahmad S, Saggar R, Libre E, Lynch JP 3rd et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir. Med. 2008;102:1305-10.
54. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, Lynch JP 3rd, Ardehali A, Goldin J. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-9.
55. Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby T V, Du Bois RM, Hansell DM. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am. J. Respir. Crit. Care Med. 2003;167:962-9.
56. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med. 2003;168:531-7.
57. Du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am. J. Respir. Crit. Care Med. 2011;183:1231-7.
58. Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am. J. Respir. Crit. Care Med. 2006;174:803-9.
59. Hanson D, Winterbauer RH, Kirtland SH, Wu R. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 1995;108:305-10.
60. Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur. Respir. J. 2010;35:830-6.
61. Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2011;183:431-40.
62. Du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2011;184:459-66.
63. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007;175:705-11.